BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25971931)

  • 1. Epigallocatechin-3-gallate-induced free-radical production upon adipogenic differentiation in bovine bone-marrow mesenchymal stem cells.
    Jeong JY; Park MN; Cho ES; Jang HJ; Park S; Lee HJ
    Cell Tissue Res; 2015 Oct; 362(1):87-96. PubMed ID: 25971931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin-3-gallate suppresses the lipid deposition through the apoptosis during differentiation in bovine bone marrow mesenchymal stem cells.
    Jeong JY; Suresh S; Jang M; Park MN; Gobianand K; You S; Yeon SH; Lee HJ
    Cell Biol Int; 2015 Jan; 39(1):52-64. PubMed ID: 25044539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Cytotoxicity and the Anti-Adipogenic Effect of Green Tea Polyphenols with Epigallocatechin-3-Gallate in 3T3-L1 Preadipocytes.
    Lao W; Tan Y; Jin X; Xiao L; Kim JJ; Qu X
    Am J Chin Med; 2015; 43(6):1177-90. PubMed ID: 26446202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsaicin inhibits the adipogenic differentiation of bone marrow mesenchymal stem cells by regulating cell proliferation, apoptosis, oxidative and nitrosative stress.
    Ibrahim M; Jang M; Park M; Gobianand K; You S; Yeon SH; Park S; Kim MJ; Lee HJ
    Food Funct; 2015 Jul; 6(7):2165-78. PubMed ID: 25994559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-adipogenic effects of (-)epigallocatechin gallate are dependent on the WNT/β-catenin pathway.
    Lee H; Bae S; Yoon Y
    J Nutr Biochem; 2013 Jul; 24(7):1232-40. PubMed ID: 23318137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin-3-gallate (EGCG) as a pro-osteogenic agent to enhance osteogenic differentiation of mesenchymal stem cells from human bone marrow: an in vitro study.
    Jin P; Wu H; Xu G; Zheng L; Zhao J
    Cell Tissue Res; 2014 May; 356(2):381-90. PubMed ID: 24682582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin-3-gallate protects against tumor necrosis factor alpha induced inhibition of osteogenesis of mesenchymal stem cells.
    Liu W; Fan JB; Xu DW; Zhang J; Cui ZM
    Exp Biol Med (Maywood); 2016 Mar; 241(6):658-66. PubMed ID: 26748399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.
    Lee MS; Kim CT; Kim Y
    Ann Nutr Metab; 2009; 54(2):151-7. PubMed ID: 19390166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Epigallocatechin-3-Gallate (EGCG) Enhances Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells.
    Lin SY; Kang L; Wang CZ; Huang HH; Cheng TL; Huang HT; Lee MJ; Lin YS; Ho ML; Wang GJ; Chen CH
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30563251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGCG Inhibits Adipose-Derived Mesenchymal Stem Cells Differentiation into Adipocytes and Prevents a STAT3-Mediated Paracrine Oncogenic Control of Triple-Negative Breast Cancer Cell Invasive Phenotype.
    Gonzalez Suarez N; Rodriguez Torres S; Ouanouki A; El Cheikh-Hussein L; Annabi B
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33801973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of green tea (-)-epigallocatechin-3-gallate on reactive oxygen species in 3T3-L1 preadipocytes and adipocytes depend on the glutathione and 67 kDa laminin receptor pathways.
    Wang CT; Chang HH; Hsiao CH; Lee MJ; Ku HC; Hu YJ; Kao YH
    Mol Nutr Food Res; 2009 Mar; 53(3):349-60. PubMed ID: 19065584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-bone and antifat effects of green tea and its polyphenol, epigallocatechin, in rat mesenchymal stem cells in vitro.
    Ko CH; Siu WS; Wong HL; Shum WT; Fung KP; San Lau CB; Leung PC
    J Agric Food Chem; 2011 Sep; 59(18):9870-6. PubMed ID: 21877759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green tea polyphenol (-)-epigallocatechin gallate suppressed the differentiation of murine osteoblastic MC3T3-E1 cells.
    Kamon M; Zhao R; Sakamoto K
    Cell Biol Int; 2009 Dec; 34(1):109-16. PubMed ID: 19947947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the mitochondrial oxidative stress in the cytotoxic effects of the green tea catechin, (-)-epigallocatechin-3-gallate, in oral cells.
    Tao L; Forester SC; Lambert JD
    Mol Nutr Food Res; 2014 Apr; 58(4):665-76. PubMed ID: 24249144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of green tea extract and (-)-epigallocatechin-3-gallate on mammalian thioredoxin reductase and HeLa cell viability.
    Wang Y; Zhang H; Holmgren A; Tian W; Zhong L
    Oncol Rep; 2008 Dec; 20(6):1479-87. PubMed ID: 19020731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
    Yamauchi R; Sasaki K; Yoshida K
    Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota facilitates the formation of the aminated metabolite of green tea polyphenol (-)-epigallocatechin-3-gallate which trap deleterious reactive endogenous metabolites.
    Zhang S; Zhao Y; Ohland C; Jobin C; Sang S
    Free Radic Biol Med; 2019 Feb; 131():332-344. PubMed ID: 30578921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin Gallate Inhibits Mouse Mesenchymal Stem Cell Differentiation to Adipogenic Lineage.
    Chani B; Puri V; Chander Sobti R; Puri S
    J Stem Cells Regen Med; 2016; 12(1):16-24. PubMed ID: 27397998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocatechin gallate-induced apoptosis does not affect adipocyte conversion of preadipocytes.
    Morikawa K; Ikeda C; Nonaka M; Pei S; Mochizuki M; Mori A; Yamada S
    Cell Biol Int; 2007 Nov; 31(11):1379-87. PubMed ID: 17631393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species.
    Nakazato T; Ito K; Ikeda Y; Kizaki M
    Clin Cancer Res; 2005 Aug; 11(16):6040-9. PubMed ID: 16115949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.